In its supervisory enhancement programme (SEP) the FSA stated that it would place greater emphasis on the role of senior management, including non-executive directors (NEDs). Today's policy statement sets out changes to the approved persons regime which improves FSA's approach to ‘significant influence' functions by ensuring that those likely to exert a significant influence on a firm fall within the scope of the approved persons regime.
In particular, the FSA has:
- Extended the scope and application of CF1 (director function) and CF2 (Non- Executive Director) to include those persons employed by an unregulated parent undertaking or holding company, whose decisions or actions are regularly taken into account by the governing body of a regulated firm;
- Extended the definition of the significant management controlled function (CF29) to include all proprietary traders who are not senior managers but who are likely to exert significant influence on a firm; and,
- Amended the application of the approved persons regime to UK branches of overseas firms based outside the EEA.
Graeme Ashley-Fenn, director of permissions, decisions and reporting division, said: "It is important that directors and senior managers at firms understand their regulatory obligations and have the relevant competencies and experience to carry out their roles with integrity.
"Since October 2008, the FSA has carried out 115 interviews for ‘significant influence' posts at high impact firms. Nine applications have been withdrawn as a result. Once in post, where individuals fail to meet the required standards the FSA will consider enforcement action."
These changes will come into effect on 6 August 2009 with a transitional period of six months. Firms should now begin assessing which individuals require approval and submit timely applications to comply with the end of the transitional period
